韩国裸舞

New perspectives on Management and Therapeutics for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Speaker: Dr. Giada Sebastiani, MD FAASLD

Professor of Medicine,聽韩国裸舞 Health Centre
Research Director, Division of Gastroenterology and Hepatology
Division of Infectious Diseases, Clinician Scientist at the Research Institute of 韩国裸舞 Health Centre
Chercheur boursier Senior du FRQ-S

At the end of the presentation, the audience will:

1. Recognize the evolving landscape of MASLD management by identifying key risk factors, current diagnostic approaches, and the role of primary care and specialists in disease stratification and monitoring.2. Evaluate emerging therapeutic strategies for MASLD and MASH, including lifestyle interventions, metabolic-based pharmacotherapies (GLP-1RAs, SGLT2 inhibitors, and dual GIP/GLP-1 agonists), and the future role of MASLD-specific treatments in clinical practice.
2. Evaluate emerging therapeutic strategies for MASLD and MASH, including lifestyle interventions, metabolic-based pharmacotherapies (GLP-1RAs, SGLT2 inhibitors, and dual GIP/GLP-1 agonists), and the future role of MASLD-specific treatments in clinical practice.

搁辞辞尘:听顿02.1312

Zoom link:

Full MUHC Grand Rounds Schedule